BRIEF published on 06/29/2026 at 15:32, 2 months 13 days ago The Vanguard Group's Stake in LondonMetric Property and Schroder Real Estate Real Estate Investment Form 8.3 Vanguard Group LondonMetric Property Schroder Real Estate
PRESS RELEASE published on 06/29/2026 at 15:31, 2 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc. The Vanguard Group, Inc. discloses a 13.52% interest in Prologis, Inc. through Form 8.3 filing on 29-Jun-2026 Form 8.3 Disclosure The Vanguard Group Interest Prologis Inc.
PRESS RELEASE published on 06/29/2026 at 15:30, 2 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses a 5.05% stake in Picton Property Income Limited as of 26 June 2026 under Form 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure Picton Property Income Limited
PRESS RELEASE published on 06/29/2026 at 15:29, 2 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Forward Industries Inc. The Vanguard Group, Inc. discloses a 4.80% stake in Forward Industries Inc. as per Form 8.3 filed with the Irish Takeover Panel on 29 June 2026 Form 8.3 Disclosure Irish Takeover Panel Vanguard Group Forward Industries Inc.
PRESS RELEASE published on 06/29/2026 at 15:27, 2 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses ownership of 4.97% of Beazley plc's relevant securities. Details of securities transactions provided The Vanguard Group Ownership Disclosure Securities Transactions Beazley Plc
PRESS RELEASE published on 06/29/2026 at 15:27, 2 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses 5.28% interest in LondonMetric Property plc and 0.94% interest in Schroder Real Estate Investment Trust Limited as of 26 June 2026 Securities LondonMetric Property Plc Disclosure Vanguard Group Schroder Real Estate
BRIEF published on 06/26/2026 at 15:28, 2 months 16 days ago The Vanguard Group, Inc.: Disclosure on Tate & Lyle plc Takeover Code Securities Disclosure Vanguard Group Shareholding Tate & Lyle
BRIEF published on 06/26/2026 at 15:28, 2 months 16 days ago The Vanguard Group's Disclosure on Spire Healthcare Group Plc Form 8.3 Takeover Code Vanguard Group Spire Healthcare Securities Position
BRIEF published on 06/26/2026 at 15:26, 2 months 16 days ago The Vanguard Group, Inc. Discloses Position in SEGRO plc Form 8.3 Takeover Code Vanguard Group SEGRO PLC Securities Position
BRIEF published on 06/26/2026 at 15:26, 2 months 16 days ago The Vanguard Group Discloses Position in Schroders plc Takeover Code Securities Disclosure Schroders Plc Vanguard Group Shareholding
Published on 09/12/2026 at 02:35, 1 day 9 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 12 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 14 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 18 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 17 hours 49 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 4 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 13 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 13 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 15 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 4 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 2 days 16 hours ago Availability of the 2026 Interim Financial Report
